This document discusses succinylcholine (also known as suxamethonium), a depolarizing neuromuscular blocking agent used in medical procedures requiring short-term muscle paralysis. It describes succinylcholine's mechanism of action as mimicking acetylcholine to initially stimulate nicotinic receptors, followed by desensitization. The document outlines factors that affect succinylcholine's short duration such as its breakdown by plasma cholinesterase and genetic variations in this enzyme. Key indications for succinylcholine include endotracheal intubation and electroconvulsive therapy due to its extremely fast onset and short duration of action.